Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human CD71/TFRC Antibody (TfR006) | Login | Anti-Human CD71/TFRC Antibody (TfR006) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD19 Antibody (SAA2206) | Login | Anti-Human CD19 Antibody (SAA2206) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD20/MS4A1 Antibody (SAA2208) | Login | Anti-Human CD20/MS4A1 Antibody (SAA2208) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD20/MS4A1 Antibody (SAA2209) | Login | Anti-Human CD20/MS4A1 Antibody (SAA2209) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD20/MS4A1 Antibody (SAA2210) | Login | Anti-Human CD20/MS4A1 Antibody (SAA2210) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD227/MUC1 Antibody (SAA2216) | Login | Anti-Human CD227/MUC1 Antibody (SAA2216) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD227/MUC1 Antibody (HMFG1) | Login | Anti-Human CD227/MUC1 Antibody (HMFG1) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD56/NCAM1 Antibody (SAA2213) | Login | Anti-Human CD56/NCAM1 Antibody (SAA2213) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human PSCA Antibody (Ha1-4.117) | Login | Anti-Human PSCA Antibody (Ha1-4.117) | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tabalumab | Login | Research Grade Tabalumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vopratelimab | Login | Research Grade Vopratelimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Feladilimab | Login | Research Grade Feladilimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tabituximab | Login | Research Grade Tabituximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tepoditamab | Login | Research Grade Tepoditamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ponezumab | Login | Research Grade Ponezumab | ||||||||||||||||
|
||||||||||||||||||
| Anti-RBFOX3 Antibody (R2T17) | Login | Anti-RBFOX3 Antibody (R2T17) | ||||||||||||||||
|
||||||||||||||||||
| Anti-RBFOX3 Antibody (R2T18) | Login | Anti-RBFOX3 Antibody (R2T18) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD261/TNFRSF10A Antibody (R2T26) | Login | Anti-CD261/TNFRSF10A Antibody (R2T26) | ||||||||||||||||
|
||||||||||||||||||
| Anti-MEN1 Antibody (R2T31) | Login | Anti-MEN1 Antibody (R2T31) | ||||||||||||||||
|
||||||||||||||||||
| Anti-DFFA Antibody (R2T35) | Login | Anti-DFFA Antibody (R2T35) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HIP1 Antibody (R2T36) | Login | Anti-HIP1 Antibody (R2T36) | ||||||||||||||||
|
||||||||||||||||||
| Anti-WASL Antibody (R2T42) | Login | Anti-WASL Antibody (R2T42) | ||||||||||||||||
|
||||||||||||||||||
| Anti-IGF2BP3 Antibody (R2T44) | Login | Anti-IGF2BP3 Antibody (R2T44) | ||||||||||||||||
|
||||||||||||||||||
| Anti-IGF2BP3 Antibody (R2T45) | Login | Anti-IGF2BP3 Antibody (R2T45) | ||||||||||||||||
|
||||||||||||||||||
| Anti-IGF2BP3 Antibody (R2T46) | Login | Anti-IGF2BP3 Antibody (R2T46) | ||||||||||||||||
|
||||||||||||||||||


